Press "Enter" to skip to content

Pancreas Ca for Jeopardy! Host; Mind and Mortality; Q6W Keytruda Dosing

Longtime “Jeopardy!” host Alex Trebek announced his diagnosis of stage IV pancreatic cancer on Wednesday, and said he plans “to beat the low survival rate statistics” associated with the disease. (New York Times)

A patient with metastatic pancreatic cancer exhibited a “remarkable” response with a combination of two already-approved agents, neither of which had shown activity against the disease alone. (Huntsman Cancer Institute, Nature Medicine)

Shortages of chemotherapy agents for pediatric cancers could threaten recent gains in favorable outcomes. (Baylor College of Medicine, JAMA Pediatrics)

Recent survey data found that two-thirds of workers at community cancer centers were feeling “a great deal of stress” because of their jobs. (ACCC)

An emergency room visit or psychiatric hospitalization in the years prior to a cancer diagnosis were found to increase risk of cancer mortality by 36% and 73%, respectively. (British Journal of Cancer)

Artificial intelligence is now ready to take on pathologists for diagnosing lung cancer. (Scientific Reports)

Interviews with 40 long-term breast cancer survivors yielded nine “actionable” recommendations that could help others reduce their risk of long-lasting financial toxicity following a cancer diagnosis. (Johns Hopkins Bloomberg School of Public Health, Cancer)

Updated phase II trial data show more responses, including another complete remission, in acute myeloid leukemia (AML) patients treated with low-dose cytarabine plus the novel agent prexigebersen, developer Bio-Path announced.

As adjuvant treatment for brain metastases shifts away from whole-brain radiation toward stereotactic radiation, a new difficult-to-salvage problem has emerged: pachymeningeal seeding. (JAMA Oncology)

Cancer patients across the pond starting on pembrolizumab (Keytruda) monotherapy may soon receive a more patient-friendly every-6-week dosing schedule following a positive opinion from the European Medicines Agency, Merck announced.

The American College of Radiology and American Association of Physicists in Medicine are looking to allay the public’s concerns after last week’s report that an Arizona crematory had detected radioactive material in their machinery following the cremation of a man who had been treated with a radionuclide therapy for his cancer. (Radiology Business)